ConductScience.org, home

Paper11296091

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

Huestis MA and 6 others. Arch Gen Psychiatry, 2001. Cited by 355 papers, by iCite.

Cite this record

ConductScience Library. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Papers, record 11296091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11296091

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
PubMed
Journal
Arch Gen Psychiatry
PubMed
Year
2001
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
355
iCite
Relative citation ratio, by iCite
9.83
iCite
Revised in PubMed
2019-07-17
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huestis MAM A
2Gorelick DAD A
3Heishman SJS J
4Preston KLK L
5Nelson RAR A
6Moolchan ETE T
7Frank RAR A

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CannabinoidsMajor topic
DronabinolMajor topic
Marijuana AbuseMajor topic
PiperidinesMajor topic
PyrazolesMajor topic
Receptors, DrugMajor topic
Administration, Oral
Adult
Animals
Dose-Response Relationship, Drug
Double-Blind Method
Euphoria
Heart Rate
Humans
Male
Placebos
Receptors, Cannabinoid
Rimonabant
Tachycardia

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z01DA000240NIHNIH RePORTER
Z01DA000409NIHNIH RePORTER
Z01DA000413NIHNIH RePORTER
ZIADA000240NIHNIH RePORTER
ZIADA000413NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01037608Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationBackgroundClinicalTrials.gov
NCT01071616Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked CannabisBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in11296092Cannabinoid antagonists: a treatment in search of an illness.https://conductscience.org/library/papers/11296092

Source PubMed

Download CSV of comments and corrections

Cited by189

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 355 citations.

PMIDTitleJournalYearIn PapersSource
42745361(+)-Trans-Cannabidiol Is an Agonist at Human CB2 Receptors.Pharmacol Res Perspect2026https://conductscience.org/library/papers/42745361PubMed
42351388Deficits in episodic memory and executive functions in relation to CB1 receptor availability in Parkinson's disease.J Parkinsons Dis2026https://conductscience.org/library/papers/42351388PubMed
41959067Cannabidiol dose modulates behavioral response to acute and repeated administration of Δ9-Tetrahydrocannabinol by strain and sex.bioRxiv2026https://conductscience.org/library/papers/41959067PubMed
41760917Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies.Mol Psychiatry2026https://conductscience.org/library/papers/41760917PubMed
41565997The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting NaV1.7 and NaV1.8 nociceptive sodium channels.Neuropsychopharmacology2026https://conductscience.org/library/papers/41565997PubMed
40760404Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Curr Top Behav Neurosci2026https://conductscience.org/library/papers/40760404PubMed
39898464CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.Clin Pharmacol Ther2025https://conductscience.org/library/papers/39898464PubMed
39813001Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.Curr Top Behav Neurosci2026https://conductscience.org/library/papers/39813001PubMed
39796008Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.Int J Mol Sci2024https://conductscience.org/library/papers/39796008PubMed
39575727Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function.J Am Heart Assoc2024https://conductscience.org/library/papers/39575727PubMed
39494344Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity.Front Pharmacol2024https://conductscience.org/library/papers/39494344PubMed
39388076Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action.Drugs2024https://conductscience.org/library/papers/39388076PubMed
39331072Cannabinoids and the heart-a psychiatrist's perspective.Herz2024https://conductscience.org/library/papers/39331072PubMed
39250476Multi-modal and bi-directional effects of a synthetic Δ9-Tetrahydrocannabinol (THC) analogue, Nabilone, on spatio-temporal binding windows: Evidence from the projected hand illusion.PLoS One2024https://conductscience.org/library/papers/39250476PubMed
38892456Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality.Int J Mol Sci2024https://conductscience.org/library/papers/38892456PubMed
37671673The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.Psychol Med2023https://conductscience.org/library/papers/37671673PubMed
37574376Cannabis use and sleep disturbances among White, Black, and Latino adults in the United States: A cross-sectional study of National Comorbidity Survey-Replication (2001-2003) data.Sleep Health2023https://conductscience.org/library/papers/37574376PubMed
36695881The medial prefrontal cortex and the cardiac baroreflex activity: physiological and pathological implications.Pflugers Arch2023https://conductscience.org/library/papers/36695881PubMed
36674936Human Astrocyte Spheroids as Suitable In Vitro Screening Model to Evaluate Synthetic Cannabinoid MAM2201-Induced Effects on CNS.Int J Mol Sci2023https://conductscience.org/library/papers/36674936PubMed
36638804THC and CBD: Similarities and differences between siblings.Neuron2023https://conductscience.org/library/papers/36638804PubMed

See all 189 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CNR11268PubTator's text mininghttps://conductscience.org/library/genes/1268

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11296091

GET https://conductscience.org/api/papers/v1/11296091/cited_by?page=2